Population Pharmacokinetic Modeling of Remifentanil in Infants with Unrepaired Tetralogy of Fallot

ConclusionsUnrepaired TOF does not change the pharmacokinetics of remifentanil, suggesting a similar dosage for infants with TOF compared to normal cardiac anatomy infants.Clinical Trial RegistrationThe patient enrollment in this study started at 2012, so we do not have clinic trial number, but we still think this is a valuable research and hope it could be considered for publication.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research